ICU Medical Q2 Adjusted EPS USD 2.37 Vs. IBES Estimate USD 1.91
ICUI•Q2 earnings beat estimates
Aug. 6 (Reuters) - ICU Medical Q2 revenue was USD 551.683 million versus the IBES estimate of USD 533.4 million.
- Q2 adjusted EPS: USD 2.37 vs. IBES estimate USD 1.91
- Q2 gross profit: USD 235.053 million
- Q2 gross margin: 43%
- Q2 adjusted EBITDA: USD 110 million vs. IBES estimate USD 101 million




